Title: Publications


6. Yan B, Mu Y, Liu Y, Xiang J, Zhang Q, Zhai S, __Russo D P__, Zhu H, Bai X From fighting depression to conquering tumors: a novel 
tricyclic thiazepine compound as a tubulin polymerization inhibitor Cell Death and Disease. In press.

5. Ball N, Cronin M T, Shen J, Adenuga M D, Blackburn K, Booth E D, Bouhifd M, Donley E, Egnash L, Freeman J J, Hastings C, Juberg D R, 
Kleensang A, Kleinstreuer N, Kroese E D, Luechtefeld T, Maertens A, Marty S, Naciff J M, Palmer J, Pamies D, Penman M, Richarz A N, 
__Russo D P__, Stuard S B, Patlewicz G, van Ravenzwaay B, Wu S, Zhu H, Hartung T Toward Good Read-Across Practice (GRAP) guidance. 
ALTEX. In press.

4. Luechtefeld T, Maertens A, __Russo D P__, Rovida C, Zhu H, Hartung T Analysis of publically available skin sensitization data from 
REACH registrations 2008-2014. ALTEX. In press.

3. Luechtefeld T, Maertens A, __Russo D P__, Rovida C, Zhu H, Hartung T Analysis of Draize eye irritation testing and its prediction by mining 
publicly available 2008-2014 REACH data. ALTEX. In press.

2. Luechtefeld T, Maertens A, __Russo D P__, Rovida C, Zhu H, Hartung T Analysis of public oral toxicity data from REACH registrations 
2008-2014. ALTEX. In press.

1. Luechtefeld T, Maertens A, __Russo D P__, Rovida C, Zhu H, Hartung T Global analysis of publicly available safety data for 9,801 substances 
registered under REACH from 2008-2014. ALTEX. In press.  